Yasuhiro Yamauchi to Chemotherapy, Adjuvant
This is a "connection" page, showing publications Yasuhiro Yamauchi has written about Chemotherapy, Adjuvant.
Connection Strength
0.352
-
Urushiyama H, Jo T, Yasunaga H, Michihata N, Matsui H, Hasegawa W, Takeshima H, Sakamoto Y, Hiraishi Y, Mitani A, Fushimi K, Nagase T, Yamauchi Y. Oral fluorouracil vs vinorelbine plus cisplatin as adjuvant chemotherapy for stage II-IIIA non-small cell lung cancer: Propensity score-matched and instrumental variable analyses. Cancer Med. 2018 10; 7(10):4863-4869.
Score: 0.162
-
Urushiyama H, Jo T, Yasunaga H, Yamauchi Y, Matsui H, Hasegawa W, Takeshima H, Hiraishi Y, Mitani A, Fushimi K, Nagase T. Adjuvant chemotherapy versus chemoradiotherapy for small cell lung cancer with lymph node metastasis: a retrospective observational study with use of a national database in Japan. BMC Cancer. 2017 Sep 02; 17(1):613.
Score: 0.151
-
Sato C, Okuda K, Tamiya H, Yamamoto K, Hoshina K, Narumoto O, Urushiyama H, Noguchi S, Amano Y, Watanabe K, Mitani A, Kage H, Tanaka G, Yamauchi Y, Takai D, Nagase T. Acute Arterial Thrombosis during Postoperative Adjuvant Cisplatin-based Chemotherapy for Completely Resected Lung Adenocarcinoma. Intern Med. 2018 Feb 15; 57(4):557-561.
Score: 0.039